Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsa M Cora

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Experimental Cell Research|August 9, 2008
Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cellsMarianela Perez-Torres, Blanca L Valle, Nita J Maihle, et al.
Biochemistry and Biophysics Reports|August 30, 2022
Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cellsLisandra Negrón-Vega, Elsa M Cora, Marianela Pérez-Torres, et al.
Biochemistry|June 5, 2013
Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximabJason A Wilken, Marianela Perez-Torres, Rene Nieves-Alicea, et al.
Cancer Research|April 19, 2005
Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozoleJacqueline M Lafky, Andre T Baron, Elsa M Cora, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancerAndre T Baron, Elsa M Cora, Jacqueline M Lafky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancerMassimo Cristofanilli, Vicente Valero, Aroop Mangalik, et al.
Cancer Treatment and Research|September 19, 2009
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancerAndre T Baron, Jacqueline M Lafky, Cecelia H Boardman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Experimental Cell Research|August 9, 2008
Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cellsMarianela Perez-Torres, Blanca L Valle, Nita J Maihle, et al.
Biochemistry and Biophysics Reports|August 30, 2022
Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cellsLisandra Negrón-Vega, Elsa M Cora, Marianela Pérez-Torres, et al.
Biochemistry|June 5, 2013
Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximabJason A Wilken, Marianela Perez-Torres, Rene Nieves-Alicea, et al.
Cancer Research|April 19, 2005
Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozoleJacqueline M Lafky, Andre T Baron, Elsa M Cora, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancerAndre T Baron, Elsa M Cora, Jacqueline M Lafky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancerMassimo Cristofanilli, Vicente Valero, Aroop Mangalik, et al.
Cancer Treatment and Research|September 19, 2009
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancerAndre T Baron, Jacqueline M Lafky, Cecelia H Boardman, et al.
Pageof 1